EXPLANATORY NOTE
This Form 8-A/A is filed by Zymeworks Inc. (the “Registrant”) to reflect the expiration of the preferred stock purchase rights (the “Rights”) issued pursuant to the terms of the Preferred Stock Rights Agreement, dated October 12, 2022, between the Registrant and Computershare Trust Company, N.A., as rights agent (the “Rights Agreement”).
Item 1. | Description of Registrant’s Securities to be Registered |
Item 1 is hereby amended and supplemented as follows:
On June 8, 2023, the Rights expired by their terms. This had the effect of terminating the Rights Agreement.
In connection with the termination of the Rights Agreement, the Registrant filed a Certificate of Elimination with the Secretary of State of the State of Delaware on June 12, 2023, which, effective upon filing, eliminated the Registrant’s Series B Participating Preferred Stock, par value $0.00001 per share (the “Series B Preferred Stock”). Upon effectiveness of the filing of the Certificate of Elimination, the shares that were previously designated as Series B Preferred Stock resumed the status of authorized but unissued shares of preferred stock of the Registrant.
The foregoing summary of the Certificate of Elimination does not purport to be complete and is subject to, and qualified in its entirety by reference to, the Certificate of Elimination attached as Exhibit 3.1 hereto and incorporated herein by reference.
| | |
Exhibit No. | | Description of Exhibit |
| |
3.1 | | Certificate of Elimination of Series B Participating Preferred Stock of Zymeworks Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed by the Registrant with the Securities and Exchange Commission on June 12, 2023). |
| |
4.1 | | Preferred Stock Rights Agreement, dated October 12, 2022, between the Registrant and Computershare Trust Company, N.A., as rights agent (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K12B filed by the Registrant with the Securities and Exchange Commission on October 13, 2022). |